Neoadjuvant Chemotherapy for Pancreatic Cancer; GS vs. GnP

Trial ID: NCT05268692

Interventional - Phase 2/3 - Recruiting

The effect of neoadjuvant chemotherapy for pancreatic cancer was gradually established. However it has been not clarified which regimen of neoadjuvant treatment for pancreatic cancer is the best.

Conditions

• Pancreatic Adenocarcinoma

Interventions

• GS
• GnP

Eligibility

Inclusion criteria

• elective pancreatectomy for pancreatic cancer

Exclusion criteria

• a previous cancer surgery a body weight loss of >10% during the 6 months before surgery the presence of distant metastases seriously impaired function of vital organs because of respiratory, renal, or heart disease.

Sponsor

Kochi University

Source: Clinicaltrials.gov

Search more clinical trials on myTomorrows